|Bid||53.88 x 900|
|Ask||54.02 x 800|
|Day's range||53.25 - 54.94|
|52-week range||33.36 - 54.94|
|Beta (5Y monthly)||0.67|
|PE ratio (TTM)||15.42|
|Earnings date||31 Jan 2022 - 04 Feb 2022|
|Forward dividend & yield||1.56 (2.89%)|
|Ex-dividend date||04 Nov 2021|
|1y target est||N/A|
The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday. Omicron has the world on edge because of its unique combination of mutations that might significantly reduce the effectiveness of first-generation COVID-19 vaccines. While there simply isn't enough data to draw any firm conclusions about the seriousness of the omicron variant yet, politicians across the world were quick to react by imposing travel bans and restrictions on several African nations over the weekend.
These businesses should do extremely well next year, and their stocks will probably reflect that performance.
U.S. stock futures slumped Friday as global markets plunged, amid fears surrounding a new coronavirus variant in South Africa that could lead to new lockdowns.